Back
  1. Home
  2. Profile of Adrienne Doumont (ULiège)
Profil

Doumont Adrienne

See author's contact details
Main Referenced Co-authors
Ansseau, Marc  (16)
Legros, Jean-Jacques  (7)
Cerfontaine, Jean-Luc  (4)
Geenen, Vincent  (4)
Thiry, Daniel (4)
Main Referenced Keywords
Depressive Disorder (8); Adult (7); Male (7); Female (6); Human (6);
Main Referenced Disciplines
Treatment & clinical psychology (8)
Psychiatry (7)
Endocrinology, metabolism & nutrition (1)
Theoretical & cognitive psychology (1)

Publications (total 16)

The most downloaded
480 downloads
ANSSEAU, M., Sulon, J., Doumont, A., Cerfontaine, J.-L., Legros, J.-J., Sodoyez, J.-C., & Demey-Ponsart, E. (1984). Use of saliva cortisol in the dexamethasone suppression test. Psychiatry Research, 13 (3), 203-211. doi:10.1016/0165-1781(84)90035-0 https://hdl.handle.net/2268/260746

The most cited

62 citations (OpenCitations)

ANSSEAU, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Legros, J.-J., & Franck, G. (1984). Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: A pilot study. Psychiatry Research, 12 (3), 261-272. doi:10.1016/0165-1781(84)90031-3 https://hdl.handle.net/2268/260732

Timsit-Berthier, M., Mantanus, H., Marissiaux, P., Ansseau, M., Doumont, A., Geenen, V., & Legros, J.-J. (1986). CNV and dopamine receptor reactivity: correlations with the apomorphine test. In W. C. McCallum (Ed.), Cerebral psychophysiology: Studies in event-related potentials (pp. 403-405). New York, United States: Elsevier.

ANSSEAU, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Demonceau, G., Legros, J.-J., & Franck, G. (1985). Intérêt de l'EEG de sommeil en tant que marqueur biologique des états dépressifs. Comparaison avec trois tests neuro-endocriniens. Revue d'Électroencephalographie et de Neurophysiologie Clinique, 14 (4), 343-349. doi:10.1016/S0370-4475(85)80059-9
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., Thiry, D., von Frenckell, R., & Collard, J. (1985). Initial study of methylclonazepam in generalized anxiety disorder - Evidence for greater power in the cross-over design. Psychopharmacology, 87 (2), 130-135. doi:10.1007/BF00431795
Peer Reviewed verified by ORBi

Ansseau, M., Doumont, A., Cerfontaine, J.-L., Sulon, J., Demey-Ponsart, E., Geenen, V., & Legros, J.-J. (1985). Diagnostic performance of the thirty-four hour dexamethasone suppression test. Psychoneuroendocrinology, 10, 215-219. doi:10.1016/0306-4530(85)90060-5
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., Cerfontaine, J.-L., Mantanus, H., Rousseau, J.-C., & Timsit-Berthier, M. (1984). Self-reports of anxiety level and EEG changes after a single dose of benzodiazepines: Double-blind comparison of two forms of oxazepam. Neuropsychobiology, 12 (4), 255-259. doi:10.1159/000118148
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., von Frenckell, R., & Collard, J. (1984). A long-acting benzodiazepine is more effective in divided doses [letter to the editor]. New England Journal of Medicine, 310 (8), 526. doi:10.1056/NEJM198402233100813
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., von Frenckell, R., & Collard, J. (1984). Duration of benzodiazepine clinical activity: Lack of direct relationship with plasma half-life - A comparison of single vs divided dosage schedules of prazepam. Psychopharmacology, 84 (3), 293-298. doi:10.1007/BF00555201
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., & Diricq, S. (1984). Methodology required to show clinical differences between benzodiazepines. Current Medical Research and Opinion, 8 (s4), 108-114. doi:10.1185/03007998409109548
Peer Reviewed verified by ORBi

ANSSEAU, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Legros, J.-J., & Franck, G. (1984). Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: A pilot study. Psychiatry Research, 12 (3), 261-272. doi:10.1016/0165-1781(84)90031-3
Peer Reviewed verified by ORBi

ANSSEAU, M., Sulon, J., Doumont, A., Cerfontaine, J.-L., Legros, J.-J., Sodoyez, J.-C., & Demey-Ponsart, E. (1984). Use of saliva cortisol in the dexamethasone suppression test. Psychiatry Research, 13 (3), 203-211. doi:10.1016/0165-1781(84)90035-0
Peer Reviewed verified by ORBi

Ansseau, M., Doumont, A., Thiry, D., Geenen, V., & Legros, J.-J. (1983). Interest of 5-hydroxytryptophan (5-HTP) test as a neuroendocrine marker of depressive illness. Acta Psychiatrica Belgica, 83 (1), 50-56.
Peer Reviewed verified by ORBi

ANSSEAU, M., Doumont, A., Thiry, D., & Gelders, Y. (1983). Pilot study of a specific serotonergic antagonist, pirenperone, in the treatment of anxiety disorders. Acta Psychiatrica Belgica, 83 (5), 517-524.
Peer Reviewed verified by ORBi

Legros, J.-J., Ansseau, M., Doumont, A., Geenen, V., & van Wimersma-Greidanus, T. (1983). Relationship between vasopressin, neurophysin and ACTH, cortisol plasma levels in non suppressor patients during dexamethasone suppression tests. Neuro Endocrinology Letters, 5 (5), 297-302.
Peer Reviewed verified by ORBi

ANSSEAU, M., Thiry, D., & Doumont, A. (1983). Etude clinique du lormetazepam 2mg dans l'insomnie des patients psychiatriques hospitalisés. Ars Medici, 38 (17-18), 1131-1145.
Peer reviewed

ANSSEAU, M., Doumont, A., & Cerfontaine, J.-L. (1982). De la necessite du diagnostic standardise dans la recherche en psychiatrie biologique. Essai d'integration des 'research diagnostic criteria' dans le systeme AMDP. Acta Psychiatrica Belgica, 82 (4), 422-440.
Peer Reviewed verified by ORBi

Bobon, D., Mormont, C., Doumont, A., Mirel, J., Bonhomme, P., Ansseau, M., Pellet, J., Pull, C., de Buck, R., Gernay, P., Mormont, I., Lang, F., Lejeune, J., Bronckart, C., & von Frenckell, R. (1982). Analyse factorielle de la révision française de l'échelle A.M.D.P. : résultats d'une étude internationale de 388 cas. Acta Psychiatrica Belgica, 82 (4), 371-389.
Peer Reviewed verified by ORBi

Contact ORBi